Raymond James Financial’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7M Buy
443,208
+20,875
+5% +$752K 0.01% 1575
2026
Q1
$13.1M Sell
422,333
-3,175
-0.7% -$113K ﹤0.01% 1798
2025
Q4
$15.5M Buy
425,508
+22,566
+6% +$829K ﹤0.01% 1618
2025
Q3
$12.7M Sell
402,942
-29,498
-7% -$1.06M ﹤0.01% 1741
2025
Q2
$18.4M Buy
432,440
+73,779
+21% +$3.07M 0.01% 1430
2025
Q1
$16M Sell
358,661
-153,558
-30% -$8.26M 0.01% 1485
2024
Q4
$28.1M Buy
+512,219
New +$25.9M 0.01% 1076

Other funds holding VCEL

Raymond James Financial's VCEL Position: Q2 2026 in Review

Raymond James Financial increased its Vericel Corp (VCEL) stake by 4.9% in Q2 2026, buying an estimated $752K and bringing the position to 443,208 shares worth $19.7M. The position accounts for 0.01% of the portfolio, ranked #1575.

Raymond James Financial first reported a position in VCEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $28.1M in Q4 2024. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Raymond James Financial held 443,208 shares of Vericel Corp worth $19.7M as of Q2 2026.
  • Raymond James Financial bought 20,875 Vericel Corp shares in Q2 2026, an estimated $752K.
  • Vericel Corp made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1575 holding.
  • Raymond James Financial first reported a position in Vericel Corp in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Vericel Corp position peaked at $28.1M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.